(MUV2) Münchener Rück - Ratings and Ratios
Reinsurance, Life, Health, Property, Casualty
MUV2 EPS (Earnings per Share)
MUV2 Revenue
Description: MUV2 Münchener Rück
Münchener Rück AG is a global insurance and reinsurance powerhouse operating through five key segments: Life and Health Reinsurance, Property-Casualty Reinsurance, ERGO Life and Health Germany, ERGO Property-Casualty Germany, and ERGO International. The companys diverse portfolio includes life and health reinsurance solutions, such as digital underwriting and advanced analytics, as well as property and casualty reinsurance solutions, including agricultural reinsurance and cyber risk management.
The companys innovative approach is evident in its MIRA digital suite, which includes tools like MIRA PoS and CLARA plus, designed to streamline insurance processes. Additionally, Münchener Rück AG offers a range of industry-specific solutions, including corporate risk management, green tech, and aviation and space solutions. The ERGO brand provides a variety of insurance products, such as life, property-casualty, health, and travel insurance.
From a technical analysis perspective, the stock has shown a strong upward trend, with its 200-day SMA at 504.76, indicating a significant increase in value over the long term. The current price is 571.40, slightly below its 20-day SMA of 577.16. The ATR of 12.95 (2.27%) suggests moderate volatility. Given the current technical indicators and fundamental data, such as a P/E ratio of 16.19 and a forward P/E of 12.18, the stock appears to be in a consolidation phase.
Forecasting the stocks future performance, we can expect a continued upward trend due to the companys strong market position and diversified portfolio. The reinsurance industry is expected to grow, driven by increasing global risks and a rising demand for cyber insurance and other specialty reinsurance products. With a RoE of 14.53%, Münchener Rück AG is well-positioned to capitalize on these trends. Based on the current technical and fundamental data, a potential price target could be 600, representing a 5% increase from the current price.
Investors should monitor the stocks ability to break through its 52-week high of 596.60. A successful breakout could signal further upside potential, driven by the companys strong fundamentals and growth prospects in the reinsurance market.
Additional Sources for MUV2 Stock
MUV2 Stock Overview
Market Cap in USD | 85,492m |
Sector | Financial Services |
Industry | Insurance - Reinsurance |
GiC Sub-Industry | Reinsurance |
IPO / Inception |
MUV2 Stock Ratings
Growth Rating | 93.2 |
Fundamental | 36.4 |
Dividend Rating | 79.3 |
Rel. Strength | -1.3 |
Analysts | - |
Fair Price Momentum | 622.52 EUR |
Fair Price DCF | 371.33 EUR |
MUV2 Dividends
Dividend Yield 12m | 3.85% |
Yield on Cost 5y | 10.29% |
Annual Growth 5y | 8.89% |
Payout Consistency | 98.9% |
Payout Ratio | 49.0% |
MUV2 Growth Ratios
Growth Correlation 3m | -24.8% |
Growth Correlation 12m | 91.7% |
Growth Correlation 5y | 95.2% |
CAGR 5y | 22.82% |
CAGR/Max DD 5y | 0.90 |
Sharpe Ratio 12m | 0.81 |
Alpha | 18.43 |
Beta | 0.546 |
Volatility | 24.29% |
Current Volume | 297k |
Average Volume 20d | 244.4k |
As of July 03, 2025, the stock is trading at EUR 551.60 with a total of 297,044 shares traded.
Over the past week, the price has changed by +0.04%, over one month by -4.83%, over three months by -3.07% and over the past year by +26.48%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Münchener Rück (XETRA:MUV2) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.40 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MUV2 is around 622.52 EUR . This means that MUV2 is currently undervalued and has a potential upside of +12.86% (Margin of Safety).
Münchener Rück has no consensus analysts rating.
According to our own proprietary Forecast Model, MUV2 Münchener Rück will be worth about 697.1 in July 2026. The stock is currently trading at 551.60. This means that the stock has a potential upside of +26.38%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 549.9 | -0.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 697.1 | 26.4% |